Method and composition for treating cystitis
AssigneeNanologix Research, Inc.
InventorsElliot B. Lander, Jackie R. See
Life of this patent
Estimating the term…
Abstract
A medicament for treating cystitis and a method of treatment are provided. The medicament comprises a stromal vascular fraction provided in a liposomal carrier. Optionally, the medicament also controls one or more additional agents, such as a growth factor, glycosaminoglycan, DMSO, and/or another small molecule used to treat cystitis or having an effect on human stem cells. Cystitis is treated by intravesically administering to a patient a therapeutically effective dose of the medicament. The SVF can be derived from a patient's own adipose cells via liposuction.
Claims25
A medicament for treating cystitis, comprising a stromal vascular fraction (SVF) in a liposomal carrier.
A medicament for treating cystitis, comprising at least one human growth factor in a liposomal carrier.
A method of treating cystitis, comprising:
- intravesically administering to a patient a therapeutically effective dose of a medicament comprising a stromal vascular fraction (“SVF”) in a liposomal carrier.
A method of treating cystitis, comprising:
- intravesically administering to a patient a therapeutically effective dose of a medicament comprising at least one human growth factor in a liposomal carrier.
Dependencies are inferred from the claim text.